Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
mRNA | MIB1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | PRKDC | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | TM9SF1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | PAFAH1B3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | MAP3K4 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | POLR2D | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | C11orf52 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |